What are direct to patient logistics?
Direct-to-patient (DtP) logistics involve delivering medications and therapies directly to patients' homes, ensuring treatment is convenient and accessible. Direct to patient healthcare models connect patients with pharmaceutical manufacturers, virtual care, and medical delivery. These models bypass traditional retail pharmacy and insurance intermediaries. By eliminating the friction of traditional supply chains, the DtP model improves affordability and access for patients. This is particularly true for those in remote or underserved communities.
This system supports both clinical trials and licensed products through temperature-controlled and pharmaceutical cold chain transport, maintaining the integrity of sensitive medications from dispatch to door.
Why consider direct-to-patient logistics?
The demand for direct to patient delivery is accelerating as pharmaceutical companies, trial sponsors, and healthcare providers seek more patient-centered approaches to care. With advanced temperature-controlled delivery and pharmaceutical cold chain capabilities, World Courier maintains the integrity of sensitive medications from dispatch to door.
Key benefits of direct to patient logistics
Maintain drug integrity
Temperature-sensitive therapies require consistent, verified cold chain management throughout their journey. World Courier's validated packaging and real-time monitoring ensure that medications arrive in full compliance with regulatory requirements, all regardless of distance or destination.
End-to-end service
World Courier manages every stage of the direct to patient delivery process, from packaging and dispatch through to proof of delivery (POD) and sample returns. Our teams work closely with customers, home healthcare professionals, and clinical sites to coordinate timing precisely around patient schedules and nurse home visits.
Legal compliance and patient safety worldwide
We adhere strictly to national and international data privacy regulations — including HIPAA in the United States and GDPR across Europe. Patient identifiers are protected throughout the shipment journey, with blinded details available through to proof of delivery. Our standard operating procedures (SOPs) provide clear guidelines for all staff interacting with patients, caregivers, and healthcare professionals.
Improved access through our global network
World Courier's global network connects patients in remote or underserved regions with the treatments and clinical trials they need. Whether delivering investigational medicinal products (IMPs) to participants in geographically dispersed rare disease trials or shipping licensed therapies to patients who lack access to specialist centers, our reach ensures no patient is left behind.
Simplified logistics
World Courier's direct to patient logistics eliminate trips to retail pharmacies by shipping temperature-sensitive and self or home-healthcare-professional administered medications directly to patients. Deliveries are coordinated to align with patient availability and dosing schedules, reducing disruption and improving treatment adherence.
As the preferred partner for enabling at-home clinical trials and direct-to-patient delivery, World Courier's global reach covers:
- 50+ countries served across our network
- Over 50 years of specialist pharmaceutical logistics experience
- 99.85% non‑excursion rate across temperature‑controlled deliveries*
- Partnerships with MRN's licensed healthcare professionals across 80+ countries.
*Non‑excursion rate is the percentage of temperature‑controlled traffic with no temperature excursions in calendar year 2025. Excludes shipments that are not temperature‑controlled.
Why choose World Courier for your direct-to-patient logistics?
Exceptional direct to patient services for happier patients
Our direct to patient delivery services are built around the patient experience. We reduce the burden of hospital visits, support at-home drug administration, and offer personalized care that fits around patients' daily lives. This approach has a direct, positive impact on treatment adherence and quality of life. For patients managing chronic or complex conditions, this is even more so true.
Precision meets professionalism, delivered
Direct-to-patient projects are inherently complex, requiring diligent coordination between sponsors, logistics teams, healthcare professionals, and patients. World Courier's teams undergo rigorous training and adhere to global standard operating procedures, ensuring consistency and excellence across every direct to patient delivery.
Partnering for better clinical trials
Our partnership with the Medical Research Network (MRN) leverages more than a decade of collaboration to deliver seamless trial execution. MRN's licensed, highly-skilled healthcare professionals operate across 80+ countries and conduct everything from patient training and vital sign assessments to complex study drug administration and biological sample collection. Together, we recruit and retain more participants in direct-to-patient clinical trials achieving more effective and patient-centered research.
Expertise in real-time tracking
World Courier's real-time location monitoring provides complete visibility across every direct to patient delivery. Using cellular data and digital tracking platforms, patients and sponsors have clarity on exactly when treatments will arrive. Combined with real-time temperature monitoring and predictive alerts, our team can intervene before any excursion occurs (where possible). Collectively this ensures medications reach patients safely and in full compliance.
Navigate direct to patient logistics complexities with a certified Customer Success Project Manager
Direct-to-patient programs can be assigned a certified Customer Success Project Manager, providing a dedicated point of contact throughout the entire lifecycle of a study or delivery program. From statement of work (SOW) development to interactive response technology (IRT) platform integration, our project managers ensure that every variable — regulatory, operational, and logistical — is managed with care.
Direct to patient insights
Crack the market
With the U.S. Food and Drug Administration (FDA) calling for greater patient diversity in clinical trials, and the need to include patients regardless of location, direct-to-patient shipments are pivotal. Dr Andrea Zobel dives into how DtP logistics enhance patient centricity, accelerate clinical trials, and ultimately bring drugs to market faster.
Discover how the industry addresses challenges related to data privacy and regulations in this insightful podcast. Listen now to learn more about achieving greater patient centricity through DtP shipments.
Discover how the industry addresses challenges related to data privacy and regulations in this insightful podcast. Listen now to learn more about achieving greater patient centricity through DtP shipments.
Direct-to-patient enabled decentralized trial success
A decentralized trial (DCT) — or direct to patient clinical trial — is an alternative approach to clinical trials that sees patients treated remotely instead of on a clinical research site.
For trial sponsors and patients alike, this dynamic direct to patient approach can offer countless benefits, including convenience, more diverse patient pools, and enhanced trial data. Here are our five steps to keep your decentralized trial on track.
For trial sponsors and patients alike, this dynamic direct to patient approach can offer countless benefits, including convenience, more diverse patient pools, and enhanced trial data. Here are our five steps to keep your decentralized trial on track.
Related insights
FAQs for direct-to-patient services
The direct-to-patient (DtP) process involves delivering medications and clinical trial materials directly to patients' homes, ensuring they receive treatments conveniently. This approach includes temperature-controlled transport, in-home storage, patient sample collection, and return of unused drugs. DtP logistics enhance accessibility and participation in clinical trials, especially for those in remote areas. World Courier supports this process with specialized logistics solutions designed for seamless delivery and patient-centric care.
Direct-to-patient logistics vary globally, influenced by local legislation and location characteristics. Some countries, like the U.S., have clear guidelines for direct to patient logistics, while others lack specific regulations or prohibit it altogether. Additionally, logistical challenges such as shelf life and poor infrastructure can impact feasibility in certain regions. Despite these challenges, World Courier's extensive network ensures broad access to direct to patient services worldwide.
World Courier securely manages patient data by adhering to global SOPs that include specific measures for handling confidential information. Additionally, dedicated resources with specialized training in customer service, operations, and transport ensure patient data is managed with utmost care to help prevent unauthorized access or breaches.
Direct to patient logistics affords greater temperature control up to the point where the patient receives it at their home where they can then immediately transfer to their own refrigerator or freezer. If patients collect IMPs from the trial site, it is very likely it will be exposed to unregulated temperatures during the journey home.
By delivering IMPs directly to patients' homes in qualified temperature-controlled solutions, temperature control is maintained from site to storage. Deliveries are coordinated with patient schedules or nurse visits to ensure proper handling. For direct from patient models, samples are collected in temperature-controlled packaging to preserve their integrity.